Key facts
- This page summarizes Peter van der Velden's Form 4 filing for Edesa Biotech, Inc. (EDSA).
- 4 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 11 Jan 2023, 14:42.
Peter van der Velden - 09 Jan 2023 Form 4 Insider Report for Edesa Biotech, Inc. (EDSA)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- EDSA
- Reported as of
- 09 Jan 2023
- Net transaction value
- -$787,716
- SEC form
- 4
- Accepted by SEC
- 11 Jan 2023, 14:42:13 UTC
- Prior SEC filing
- 26 Oct 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Peter van der Velden
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Peter van der Velden filed Form 4 for Edesa Biotech, Inc. (EDSA) on 11 Jan 2023.
Change
- Previous filing in this sequence was filed on 26 Oct 2021.
- Current net transaction value: -$787,716.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
EDSA
transaction
Common share
Sale
- Transaction value
- $353,647
- Shares
- -132,845
- Change %
- -7%
- Price
- $2.66
- Shares after
- 1,764,583
- Date
- 09 Jan 2023
- Ownership
- Held by Lumira Capital II, L.P.
- Footnotes
- F1
EDSA
transaction
Common share
Sale
- Transaction value
- $32,701
- Shares
- -12,284
- Change %
- -7%
- Price
- $2.66
- Shares after
- 163,170
- Date
- 09 Jan 2023
- Ownership
- Held by Lumira Capital II (International), L.P.
- Footnotes
- F1
EDSA
transaction
Common share
Sale
- Transaction value
- $367,395
- Shares
- -139,450
- Change %
- -7.9%
- Price
- $2.63
- Shares after
- 1,625,133
- Date
- 10 Jan 2023
- Ownership
- Held by Lumira Capital II, L.P.
- Footnotes
- F1
EDSA
transaction
Common share
Sale
- Transaction value
- $33,973
- Shares
- -12,895
- Change %
- -7.9%
- Price
- $2.63
- Shares after
- 150,275
- Date
- 10 Jan 2023
- Ownership
- Held by Lumira Capital II (International), L.P.
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Peter van der Velden is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 1 footnote
Footnote F1
This Form 4 is jointly filed by (i) Lumira Capital II, L.P. ("LCII LP"), (ii) Lumira Capital II (International), L.P. ("LCII INT LP"), (iii) Lumira Capital GP, L.P., (iv) Lumira GP Inc. (v) Lumira GP Holdings Co., and (vi) Lumira Capital Investment Management Inc. Lumira Capital GP, L.P. the general partners of which are Lumira GP Inc. and Lumira GP Holdings Co., is the general partner of LCII LP and LCII INT LP, and each of LCII LP and LCII INT LP is managed by Lumira Capital Investment Management Inc. Mr. van der Velden is an executive officer of Lumira GP Inc., Lumira GP Holdings Co., and Lumira Capital Investment Management Inc. Each of Lumira Capital GP, L.P., Lumira GP Inc., Lumira GP Holdings Co., Lumira Capital Investment Management Inc. and Mr. van der Velden may be deemed to beneficially own the shares held by LCII LP and LCII INT LP, but each disclaim beneficial ownership except to the extent of their pecuniary interest therein, if any.